The use of fluorocarbon emulsions in cancer radiotherapy

Radiotherapy and Oncology

Volumn 20, Issue SUPPL., 1991, Pages 59-64

  Guichard, Marcelle ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer radiotherapy; Perfluorochemical emulsions

Indexed keywords

FLUOSOL DA; MISONIDAZOLE; PERFLUOROOCTYL BROMIDE;

ANIMAL EXPERIMENT; CANCER GRAFT; CANCER RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MOUSE; PRIORITY JOURNAL; RADIOSENSITIZATION;

BLOOD SUBSTITUTES; COMBINED MODALITY THERAPY; DRUG COMBINATIONS; EMULSIONS; FLUOROCARBONS; HUMAN; NEOPLASMS; PLASMA SUBSTITUTES; RADIATION-SENSITIZING AGENTS; SUPPORT, NON-U.S. GOV'T;

EID: 0026069565     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-8140(91)90189-N     Document Type: Article

References (27)

1. Liver, spleen and vessels: Preliminary clinical results of CT with perfluorooctylbromide
2. Predictive assays for identifying tumors which might benefit from radiotherapy with sensitizers and/or protectors
3. Survival of mammals breathing organic liquids equilibrated with oxygen at atmospheric pressure
4. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
5. PFC as blood substitutes - an overview
6. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
7. Keynote address: Chemical manipulations of tissue oxygenation for therapeutic benefit
8. Influence of buthionine sulfoximine and misonidazole on glutathione level and radiosensitivity of human tumor xenografts
9. Toxicity of Fluosol-DA 20% as an adjuvant to radiation therapy in locally advanced head and neck carcinoma
10. The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs
11. Radiosensitization by nicotinamide in tumors and normal tissues: The importance of tissue oxygenation status
12. New high Oz carrying perfluorochemical emulsions: toxicity, radiosensitivity of GM-CFC and development of metastases in mice
13. Radioresistance of human tumor xenografts: possible mechanisms
14. Is there a time and place for radiopaque fluorocarbons?
15. Perfluorooctylbromide: A reticuloendothelial-specific and tumor-imaging agent for computed tomography
16. Perfluorochemicals as US contrast agents for tumor imaging and hepatosplenography: Preliminary clinical results
17. Clinical study of perfluorochemical whole blood substitute
18. Partial hypoxia as a cause of radioresistance in human tumor xenograft: its influence illustrated by the sensitizing effect of misonidazole and hyperbaric oxygen
19. Reassessment of criteria for the selection of perfluorochemicals for second generation blood substitutes
20. Les fluorocarbures comme substituts de l'hémoglobine pour le transport des gaz respiratoires
21. Preparation of perfluorochemical emulsions for biomedical use. Materials and Methods
22. Artificial blood substitutes as adjuncts to cancer therapy
23. Radiation enhancement of lung nodule formation in mice is not potentiated by treatment with a perfluorochemical emulsion and carbogen
24. 2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation
25. Radiosensitivity of mouse lip mucosa: influence of anaesthesia, carbogen, and a new high OZ carrying perfluorochemical emulsion
26. Carbogène et dmulsions de fluorocarbures: Comparaison de leur influence sur la radiosensibilité de tumeurs humaines hétérotransplantées et de tissus sains
27. Calcium antagonists as radiation modifiers: site specificity in relation to tumor response